Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis

Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis

Abstract Background and Aims Coagulopathy and thromboembolism are common comorbidities in cancer, and anticoagulants, such as warfarin, are needed in specific situations. This study aimed to determine the clinical relevance of prothrombin time (PT) monitoring and the clinical usefulness of warfarin...

Full description

Bibliographic Details
Main Authors: Osamu Imataki, Takeshi Arai, Makiko Uemura
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Health Science Reports
Subjects:
coagulopathy
end‐stage malignancies
prothrombin time
thromboembolism
warfarin
Online Access:https://doi.org/10.1002/hsr2.956

Internet

https://doi.org/10.1002/hsr2.956

Similar Items